Driven by GLP-1 shortages and FDA compounding restrictions, a multi-billion-dollar gray market for injectable peptides ...
Experts say the updated guidelines better calculate risk for diverse groups. But it could mean some adults should now consider treatment to lower cholesterol. A new heart disease risk calculator moved ...
The drug from Merck was OK'd for patients with artery-clogging cholesterol that persists even after taking statins.
Revised 3.2. Measurement of TC, LDL-C, HDL-C, TG, and Non–HDL-C COR 2a: For adults with an LDL-C level <70 mg/dL (<1.8 mmol/L), measurement of direct LDL-C or modified LDL-C estimate is reasonable to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results